Przejdź do
Wybierz wielkość
| Do Państwa/SKU | Dostępność | Cena netto |
|---|---|---|
20 μg | Wysyłka zazwyczaj następuje w ciągu 3 tygodni (od 4 do 6 tygodni w przypadku zamówień niestandardowych). | 956,00 zł |
50 μg | Wysyłka zazwyczaj następuje w ciągu 3 tygodni (od 4 do 6 tygodni w przypadku zamówień niestandardowych). | 1720,00 zł |
Informacje o tej pozycji
956,00 zł
description
Powered by Eupheria Biotech
Quality Segment
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
AGGAACGTCTCTGTGCGAAGAGATAATGAGTTTAGCTCTGAGAAGTGAGCTTGTAGTGGACAAAACAAAGAGGAAAAAAAGAAGAGAACTGTCTGAGGAACAGAAACAAGAAATTAAAGATGCTTTTGAACTATTTGATACAGACAAAGATGAAGCAATAGATTATCATGAATTAAAGGTGGCAATGAGAGCCTTGGGGTTTGATGTAAAAAAAGCTGATGTACTGAAGATTCTTAAAGATTATGACAGAGAAGCCACAGGGAAAATCACCTTTGAAGATTTTAATGAAGTTGTGACAGACTGGATATTGGAAAGAGATCCCCATGAAGAAATACTCAAGGCATTTAAACTATTTGATGATGATGATTCAGGTAAAATAAGCTTGAGGAATTTGCGACGTGTTGCTA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... CETN3(1070)
General description
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description targeting human CETN3 | description targeting human CNTN3 | description targeting human CETN1 | description targeting human CETN2 |
| product line MISSION® | product line MISSION® | product line MISSION® | product line MISSION® |
| Ensembl | human accession no. | Ensembl | human accession no. | Ensembl | human accession no. | Ensembl | human accession no. |
| esiRNA cDNA target sequence AGGAACGTCTCTGTGCGAAGAGATAATGAGTTTAGCTCTGAGAAGTGAGCTTGTAGTGGACAAAACAAAGAGGAAAAAAAGAAGAGAACTGTCTGAGGAACAGAAACAAGAAATTAAAGATGCTTTTGAACTATTTGATACAGACAAAGATGAAGCAATAGATTATCATGAATTAAAGGTGGCAATGAGAGCCTTGGGGTTTGATGTAAAAAAAGCTGATGTACTGAAGATTCTTAAAGATTATGACAGAGAAGCCACAGGGAAAATCACCTTTGAAGATTTTAATGAAGTTGTGACAGACTGGATATTGGAAAGAGATCCCCATGAAGAAATACTCAAGGCATTTAAACTATTTGATGATGATGATTCAGGTAAAATAAGCTTGAGGAATTTGCGACGTGTTGCTA | esiRNA cDNA target sequence AAAGCAAATGGCACAACACATTTGGTTGTTACGGAACCAACAAGAATAACTTTGGCACCATCTAACATGGATGTTTCTGTTGGTGAAAGCGTCATATTGCCCTGCCAGGTACAACATGACCCGCTGTTAGACATCATCTTTACCTGGTATTTCAATGGGGCCCTTGCAGATTTTAAGAAAGATGGATCTCACTTTGAGAAAGTTGGTGGGAGTTCATCTGGTGATTTAATGATCAGAAACATTCAGCTGAAACACAGTGGGAAATATGTTTGTATGGTGCAAACGGGGGTGGACAGTGTTTCATCTGCTGCTGACCTCATAGTAAGAGGTTCACCTGGACCACCAGAAAATGTGAAGGTAGATGAAATTACAGACACAACAGCCCAACTCTCTTGGAAAGAAGGTAAAGACAACCATAGCCCAGTTATATCCTATTCTATCCAGGCTCGGACAC | esiRNA cDNA target sequence TCAAAAACCTGAAGCGTGTGGCCAACGAGCTGGGGGAGAACCTCACGGATGAGGAGCTGCAGGAGATGATCGACGAAGCTGATCGGGATGGGGACGGCGAAGTGAACGAGGAGGAGTTCCTTCGGATCATGAAGAAGACCAGCCTTTACTGAAGTCGGTTCAGAAGCTAAAGTGACTCTCTGGGTTGCCTGCTTCCATTTTGTGAAACCTTAGAGGACAGCGGCTGCCTGTCCCTTCTTCACCCCCTCACCCCCATAATTTGTCTAGATCTATTTCCATATCTCTAGTTCAATAATAGAATTTGAAAGATGCTTGTAATGTGAGTTTTGGGTTTTAATTCTCAAGAGTCAACCTGGAGCACATGAGGTTAAACAAAGGGCCCTGAAGTTTGAGTGCGCCCTCCATTTGCCCTGTGCTGAACTTGCTGTTCATCTGTTGATCTGGAGGCAGGACAGCTTCTGGGACACACAAA | esiRNA cDNA target sequence GGAGTTGGGTGAGAACCTGACTGATGAGGAGCTGCAGGAAATGATTGATGAAGCTGATCGAGATGGAGATGGAGAGGTCAGTGAGCAAGAGTTCCTGCGCATCATGAAAAAGACCAGCCTCTATTAAGATCAGTGTCTTCTTTTTCTACTGCAAGCACATGTAACTAGATTTAGTGCCTGCCATGGTGTGAAATCTGGCTTTTGAGAACACAAACTTTTCCCCCACGGACCTCCCTTTATCACTTTAATAGTGACCTTGAGCCTATTTTAGCCGTTTGGAAGTGTTCTTTGATATTACAGTTCTTTGTAAAATGACCTGCGAATTACCCTAATTCTCAAAAGCAAAACAAGAGCACACAAGCGTGAAGAAAAGGATCTTAAAGCTTTGAGCACCTGCCATTTTGCCTTGCATCGTTTCCCTCGTCATGCATTT |
| Gene Information human ... CETN3(1070) | Gene Information human ... CNTN3(5067) | Gene Information human ... CETN1(1068) | Gene Information human ... CETN2(1069) |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| NCBI accession no. | NCBI accession no. | NCBI accession no. | NCBI accession no. |
Klasa składowania
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
